![Michael Meluzio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 M $ in data 31/08/2026
Mr. Michael Meluzio, CPA, is a Chief Accounting Officer & Vice President at Cue Biopharma, Inc. Mr. Meluzio was previously employed as a Chief Financial & Accounting Officer by Kiora Pharmaceuticals, Inc. He received his undergraduate degree from Adelphi University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,67% | 13/08/2026 | 48.961 ( 0,67% ) | 1 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CUE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/06/2026 |
| Società | Posizione | Fine |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 18/03/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Adelphi University
 Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
